Literature DB >> 31857290

Mycobacterium bovis prosthetic joint infection following intravesical instillation of BCG for bladder cancer.

Ashka Patel1, Joel Elzweig2.   

Abstract

A 91-year-old man with a history of intravesicular BCG therapy for recurrent bladder cancer and bilateral total hip arthroplasty (THA) presented with left hip pain. He was noted to have a fluid collection over the left lateral hip and hip X-ray showed loosening of the prosthetic hip stem indicative of a prosthetic joint infection (PJI). He subsequently underwent removal of the THA and insertion of an antibiotic spacer. He was discharged on intravenous ceftriaxone for presumed culture negative PJI. Intraoperative acid fast bacillus culture later grew Mycobacterium tuberculosis complex, which was then differentiated to M. bovis The M. bovis infection was thought to be a complication of the patient's prior BCG therapy. He was initially started on isoniazid, rifampin, pyrazinamide and ethambutol pending cultures and sensitivities; pyrazinamide was discontinued after M. bovis was isolated on culture and susceptibility data confirmed the expected inherent resistance of M. bovis to pyrazinamide. The patient underwent successful THA revision and remains symptom-free at 1 year. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  TB and other respiratory infections; bone and joint infections; infectious diseases; orthopaedic and trauma surgery

Mesh:

Substances:

Year:  2019        PMID: 31857290      PMCID: PMC6936370          DOI: 10.1136/bcr-2019-231830

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

Review 1.  Mycobacterium bovid infection of total knee arthroplasty after bacille Calmette-Guérin therapy for bladder cancer.

Authors:  David T Rispler; John W Stirton; Alex K Gilde; Kevin R Kane
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2015-02

2.  Mycobacterium bovis infection of total hip arthroplasty after intravesicular bacille Calmette-Guérin therapy.

Authors:  Ajay Srivastava; James Ostrander; Sidney Martin; Norman Walter
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2011-11

Review 3.  Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications.

Authors:  D L Lamm; A Steg; L Boccon-Gibod; A Morales; M G Hanna; F Pagano; O Alfthan; S Brosman; H A Fisher; G Jakse
Journal:  Prog Clin Biol Res       Date:  1989

4.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

5.  Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants.

Authors:  Kee-Yong Ha; Yang-Guk Chung; Seung-Joon Ryoo
Journal:  Spine (Phila Pa 1976)       Date:  2005-01-01       Impact factor: 3.468

6.  Myobacterium bovis peri-prosthetic hip infection with successful prosthesis retention following intravesical BCG therapy for bladder carcinoma.

Authors:  Lucy Ping Aitchison; Viran Jayanetti; Steven T Lindstrom; Ronald Sekel
Journal:  Australas Med J       Date:  2015-10-31

7.  Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy.

Authors:  J R Fishman; D T Walton; N M Flynn; D R Benson; R W deVere White
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

8.  The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer.

Authors:  L Bowyer; R R Hall; J Reading; M M Marsh
Journal:  Br J Urol       Date:  1995-02

9.  A total hip replacement infected with mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guérin for bladder cancer.

Authors:  O Reigstad; P Siewers
Journal:  J Bone Joint Surg Br       Date:  2008-02

Review 10.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

View more
  2 in total

1.  Prosthetic joint infection of the hip and knee due to Mycobacterium species: A systematic review.

Authors:  Asep Santoso; Krisna Yuarno Phatama; Sholahuddin Rhatomy; Nicolaas Cyrillus Budhiparama
Journal:  World J Orthop       Date:  2022-05-18

2.  Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report.

Authors:  Michael Riste; Pretin Davda; E Grace Smith; David H Wyllie; Martin Dedicoat; Simantini Jog; Steven Laird; Gerald Langman; Neil Jenkins; Jonathan Stevenson; Matthew K O'Shea
Journal:  BMC Infect Dis       Date:  2021-02-05       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.